Literature DB >> 1649131

Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

W Pruzanski1, S Saito, E Stefanski, P Vadas.   

Abstract

Soluble phospholipase A2 (PLA2) purified from rheumatoid synovial fluid (group II) and repurified Naja naja venom PLA2 (group I) were compared for their influence on phagocytic activity of human polymorphonuclear (PMN) and mononuclear (MO) phagocytes. Group II PLA2 reduced chemotaxis, adhesiveness, and intracellular bactericidal activity (ICBA) and induced release of muramidase from PMNs. Group I PLA2 suppressed chemotaxis, and enhanced ICBA but had no influence on other phagocytic functions. Group II PLA2 purified from synovial fluid or from placenta caused marked spontaneous superoxide generation followed by inhibition of phagocytosis-induced burst of energy. Group I Naja naja and porcine pancreatic PLA2 had no effect on superoxide generation. Group II but not group I PLA2 reduced markedly ICBA of monocytes. It may be concluded that human group II soluble PLA2, in concentrations comparable to those present in inflamed joints or in sera of patients with active arthritis or septic shock, causes spontaneous formation of the oxygen radical superoxide and release of lysosomal enzymes, and suppresses conventional phagocytic activities of PMNs and monocytes. Marked differences between group I and group II PLA2s may mean that these enzymes exert different influences on cell membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649131     DOI: 10.1007/bf00917507

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  The effect of anti-inflammatory agents and inflammation on granulocyte adherence. Evidence for regulation by plasma factors.

Authors:  R R MacGregor
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

2.  Effect of exogenous phospholipase A2 on insulin secretion from perifused rat islets.

Authors:  W Zawalich; K Zawalich
Journal:  Diabetes       Date:  1985-05       Impact factor: 9.461

Review 3.  Role of secretory phospholipases A2 in the pathobiology of disease.

Authors:  P Vadas; W Pruzanski
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

4.  Influence of cationic superoxide generation enhancing protein (SGEP) on phagocytic and intracellular bactericidal activity of human polymorphonuclear cells.

Authors:  W Pruzanski; S Saito; M Alam; N S Ranadive
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

5.  The influence of homogeneous cold agglutinins on polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; N Faird; E Keystone; M Armstrong
Journal:  Clin Immunol Immunopathol       Date:  1975-07

6.  Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calcium.

Authors:  J R Traynor; K S Authi
Journal:  Biochim Biophys Acta       Date:  1981-09-24

7.  Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.

Authors:  I Maridonneau-Parini; M Errasfa; F Russo-Marie
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.

Authors:  G Marone; B Fimiani; G Torella; S Poto; P Bianco; M Condorelli
Journal:  J Clin Lab Immunol       Date:  1983-10

9.  Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

Authors:  P Vadas; W Pruzanski; E Stefanski
Journal:  Agents Actions       Date:  1988-07

10.  The influence of lysostaphin on phagocytosis, intracellular bactericidal activity, and chemotaxis of human polymorphonuclear cells.

Authors:  W Pruzanski; S Saito; D W Nitzan
Journal:  J Lab Clin Med       Date:  1983-08
View more
  2 in total

1.  Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

Authors:  M M Haapamäki; J M Grönroos; H Nurmi; K Alanen; M Kallajoki; T J Nevalainen
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

2.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.